Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Yunkang Group Limited ( (HK:2325) ) has provided an announcement.
Yunkang Group Limited has announced the appointment of Dr. Dong Min as an independent non-executive director, effective April 10, 2025. Dr. Dong brings extensive experience in biomedicine, having held senior positions at notable companies such as Novartis and Clover Biopharmaceuticals. Her appointment is expected to enhance the company’s strategic direction and governance, potentially impacting its market positioning positively.
More about Yunkang Group Limited
YTD Price Performance: -63.74%
Average Trading Volume: 173,385
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.08B
For detailed information about 2325 stock, go to TipRanks’ Stock Analysis page.